June 17, 2015

All of us at Oak Therapeutics are extremely proud to announce that we just concluded initial preclinical testing of our anti-malarial medication ArtelutrineTM. ArtelutrineTM is a reformulation of a highly effective, World Health Organization (WHO)-approved combination...

Please reload

Featured Posts

All of us at Oak Therapeutics are extremely proud to announce that we just concluded initial preclinical testing of our anti-malarial medication Artel...

OAK THERAPEUTICS SUCCESSFULLY CONCLUDES TRIAL OF MALARIA MEDICATION

June 17, 2015

1/1
Please reload

Recent Posts
Please reload

Archive
Please reload

Search By Tags
Please reload

Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

Oak Therapeutics, Inc., 2029 Becker Drive, Lawrence, KS 66047, United States, Tel. +1-913-346-0990, Email: office@oaktherapeutics.com